日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway.

利用智能纳米颗粒重编程巨噬细胞并阻断 CD47/Sirpα 通路,从而增强肿瘤免疫疗法

Hussain Zubair, Gou Shanshan, Liu Xu, Li Mengyu, Zhang Hanyue, Ren Sumei, Han Ruxia, Liu Fangfang, Zhou Xiaowen, Qiu Lu, Wang Hongfei, Chen Zhenzhen, Liu Kangdong

Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials

探索 Clec9a 在基于树突状细胞的肿瘤免疫疗法中的分子机制和治疗潜力

Hussain, Zubair; Zhang, Yueteng; Qiu, Lu; Gou, Shanshan; Liu, Kangdong

Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming

能量传感器NFE2L1功能障碍会引发不受控制的AMPK信号传导和葡萄糖代谢重编程

Qiu, Lu; Yang, Qiufang; Zhao, Wenshan; Xing, Yadi; Li, Peng; Zhou, Xiaowen; Ning, Haoming; Shi, Ranran; Gou, Shanshan; Chen, Yalan; Zhai, Wenjie; Wu, Yahong; Li, Guodong; Chen, Zhenzhen; Ren, Yonggang; Gao, Yanfeng; Zhang, Yiguo; Qi, Yuanming

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy

CD47/SIRPα阻断肽的鉴定及其与放射治疗的协同作用在癌症免疫治疗中的应用

Wang, Hongfei; Sun, Yixuan; Zhou, Xiuman; Chen, Chunxia; Jiao, Ling; Li, Wanqiong; Gou, Shanshan; Li, Yanying; Du, Jiangfeng; Chen, Guanyu; Zhai, Wenjie; Wu, Yahong; Qi, Yuanming; Gao, Yanfeng

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.

通过阻断免疫检查点 TIGIT/PVR 的相互作用,将三碘甲状腺素重新定位为癌症免疫疗法

Zhou Xiuman, Du Jiangfeng, Wang Hongfei, Chen Chunxia, Jiao Ling, Cheng Xiangrui, Zhou Xiaowen, Chen Shaomeng, Gou Shanshan, Zhao Wenshan, Zhai Wenjie, Chen Junhui, Gao Yanfeng